Home > Annual Financials > ZIM LABORATORIES

ZIM LABORATORIES Financial Statement Analysis
[BOM: 541400|NSE : ZIMLAB]

The Revenues of ZIM LABORATORIES have increased by 3.16% YoY .
The Earnings Per Share (EPS) of ZIM LABORATORIES has decreased by -29.38 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

ZIM LABORATORIES Last 5 Annual Financial Results
[BOM: 541400|NSE : ZIMLAB]

ConsolidatedMar2025
Mar2024
Mar2023
Mar2022
Mar2021
Revenues ₹379 Cr₹367 Cr₹399 Cr₹333 Cr₹307 Cr
Expenses ₹335 Cr₹326 Cr₹347 Cr₹292 Cr₹268 Cr
Operating Profit (Excl OI) ₹44 Cr₹41 Cr₹52 Cr₹41 Cr₹40 Cr
Other Income ₹5.78 Cr₹5.18 Cr₹6.41 Cr₹4.40 Cr₹2.34 Cr
Interest ₹11 Cr₹6.92 Cr₹5.58 Cr₹8.31 Cr₹11 Cr
Depreciation ₹20 Cr₹16 Cr₹17 Cr₹16 Cr₹16 Cr
Profit Before Tax ₹18 Cr₹24 Cr₹35 Cr₹21 Cr₹10 Cr
Profit After Tax ₹12 Cr₹17 Cr₹24 Cr₹15 Cr₹7.32 Cr
Consolidated Net Profit ₹12 Cr₹17 Cr₹24 Cr₹15 Cr₹7.32 Cr
Earnings Per Share (Rs)₹2.50₹3.54₹5.01₹8.96₹4.51
PAT Margin (%)3.214.696.134.362.38
ROE(%)4.977.8613.008.654.66
ROCE(%)8.2910.1116.8212.528.70
Total Debt/Equity(x)0.450.440.300.290.50

Key Financials

Market Cap : ₹ 512.3 Cr
Revenue (TTM) : ₹ 379.0 Cr
Net Profit(TTM) : ₹ 12.2 Cr
EPS (TTM) : ₹ 2.5
P/E (TTM) : 42.1

Industry Peers & Returns1W1M1Y
ZIM LABORATORIES 1.3% 18.9% 3.5%
SUN PHARMACEUTICAL INDUSTRIES -2.5% -4.9% 8.7%
DIVIS LABORATORIES -2.7% -0.9% 42.5%
CIPLA -1.5% 0.1% -4.3%
TORRENT PHARMACEUTICALS -2.6% -3.7% 11.9%
DR REDDYS LABORATORIES -2.6% 8.3% 7.9%
MANKIND PHARMA -2.5% -8.3% 5.2%
ZYDUS LIFESCIENCES -2.6% 6.8% -13.6%
LUPIN -3.4% -3.2% 21.8%


ZIM LABORATORIES Revenues
[BOM: 541400|NSE : ZIMLAB]

Y-o-Y

3.16 %

5 Yr CAGR

5.39 %

Years Revenues % Change
Mar2025 ₹379 Cr
3.16
Mar2024 ₹367 Cr
-7.80
Mar2023 ₹399 Cr
19.52
Mar2022 ₹333 Cr
8.52
Mar2021 ₹307 Cr -


ZIM LABORATORIES Operating Profit
[BOM: 541400|NSE : ZIMLAB]

Y-o-Y

5.79 %

5 Yr CAGR

2.40 %

Years Operating Profit % Change
Mar2025 ₹44 Cr
5.79
Mar2024 ₹41 Cr
-20.49
Mar2023 ₹52 Cr
26.86
Mar2022 ₹41 Cr
3.06
Mar2021 ₹40 Cr -

Operating Margins
Y-o-Y

2.58 %

5 Yr CAGR

-2.82 %

Years Operating Margin% % Change
Mar2025 11.54%
2.58
Mar2024 11.25%
-13.73
Mar2023 13.04%
6.10
Mar2022 12.29%
-5.02
Mar2021 12.94% -

ZIM LABORATORIES Profit After Tax
[BOM: 541400|NSE : ZIMLAB]

Y-o-Y

-29.46 %

5 Yr CAGR

13.55 %

Years Profit After Tax % Change
Mar2025 ₹12 Cr
-29.46
Mar2024 ₹17 Cr
-29.42
Mar2023 ₹24 Cr
67.94
Mar2022 ₹15 Cr
98.82
Mar2021 ₹7.32 Cr -

PAT Margins
Y-o-Y

-31.56 %

5 Yr CAGR

7.77 %

Years PAT Margin(%) % Change
Mar2025 3.21 %
-31.56
Mar2024 4.69 %
-23.49
Mar2023 6.13 %
40.60
Mar2022 4.36 %
83.19
Mar2021 2.38 % -

ZIM LABORATORIES Earnings Per Share (EPS)
[BOM: 541400|NSE : ZIMLAB]

Y-o-Y

-29.38 %

5 Yr CAGR

-13.71 %

Years EPS % Change
Mar2025 ₹2.50
-29.38
Mar2024 ₹3.54
-29.34
Mar2023 ₹5.01
-44.08
Mar2022 ₹8.96
98.67
Mar2021 ₹4.51 -

ZIM LABORATORIES Return on Capital Employed (ROCE)
[BOM: 541400|NSE : ZIMLAB]

Y-o-Y

-18.00 %

5 Yr CAGR

-1.20 %

Years ROCE % Change
Mar2025 8.29%
-18.00
Mar2024 10.11%
-39.89
Mar2023 16.82%
34.35
Mar2022 12.52%
43.91
Mar2021 8.7% -

ZIM LABORATORIES Share Price vs Sensex

Current Share Price : ₹105.2
Current MarketCap: ₹ 512.3 Cr
Updated EOD on :Jun 19,2025

Share Price Returns(%) 1 Week 1 Month 1 Year
ZIM LABORATORIES

1.3%

18.9%

3.5%

SENSEX

-0.4%

0.2%

5.9%

ZIM LABORATORIES related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ZIM LABORATORIES Financials


How the annual revenues of ZIM LABORATORIES have changed ?

The Revenues of ZIM LABORATORIES have increased by 3.16% YoY .

How the Earnings per Share (EPS) of ZIM LABORATORIES have changed?

The Earnings Per Share (EPS) of ZIM LABORATORIES has decreased by -29.38 % YoY .